Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose.
Clinical trial NCT07545226 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07545226
- Sponsor
- Amgen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-21
- Primary completion
- 2026-09-03
- Enrollment
- 405
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.